135 related articles for article (PubMed ID: 11390444)
1. Cutting edge: IL-18-transgenic mice: in vivo evidence of a broad role for IL-18 in modulating immune function.
Hoshino T; Kawase Y; Okamoto M; Yokota K; Yoshino K; Yamamura K; Miyazaki J; Young HA; Oizumi K
J Immunol; 2001 Jun; 166(12):7014-8. PubMed ID: 11390444
[TBL] [Abstract][Full Text] [Related]
2. In vivo administration of IL-18 can induce IgE production through Th2 cytokine induction and up-regulation of CD40 ligand (CD154) expression on CD4+ T cells.
Hoshino T; Yagita H; Ortaldo JR; Wiltrout RH; Young HA
Eur J Immunol; 2000 Jul; 30(7):1998-2006. PubMed ID: 10940889
[TBL] [Abstract][Full Text] [Related]
3. Cellular FLIP long form-transgenic mice manifest a Th2 cytokine bias and enhanced allergic airway inflammation.
Wu W; Rinaldi L; Fortner KA; Russell JQ; Tschopp J; Irvin C; Budd RC
J Immunol; 2004 Apr; 172(8):4724-32. PubMed ID: 15067048
[TBL] [Abstract][Full Text] [Related]
4. Transgenic expression of insulin receptor substrate 2 in murine B cells alters the cell density-dependence of IgE production in vitro and enhances IgE production in vivo.
Kelly-Welch AE; Wang HY; Wang LM; Pierce JH; Jay G; Finkelman F; Keegan AD
J Immunol; 2004 Mar; 172(5):2803-10. PubMed ID: 14978080
[TBL] [Abstract][Full Text] [Related]
5. IFN-gamma-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma.
Wild JS; Sigounas A; Sur N; Siddiqui MS; Alam R; Kurimoto M; Sur S
J Immunol; 2000 Mar; 164(5):2701-10. PubMed ID: 10679111
[TBL] [Abstract][Full Text] [Related]
6. Expression of a constitutively active Stat6 in vivo alters lymphocyte homeostasis with distinct effects in T and B cells.
Bruns HA; Schindler U; Kaplan MH
J Immunol; 2003 Apr; 170(7):3478-87. PubMed ID: 12646608
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of Hlx in immature Th cells induces IFN-gamma expression.
Zheng WP; Zhao Q; Zhao X; Li B; Hubank M; Schatz DG; Flavell RA
J Immunol; 2004 Jan; 172(1):114-22. PubMed ID: 14688316
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of a defective IFN-gamma response to bacterial toxins in an atopic dermatitis model, NC/Nga mice, and the therapeutic effect of IFN-gamma, IL-12, or IL-18 on dermatitis.
Habu Y; Seki S; Takayama E; Ohkawa T; Koike Y; Ami K; Majima T; Hiraide H
J Immunol; 2001 May; 166(9):5439-47. PubMed ID: 11313381
[TBL] [Abstract][Full Text] [Related]
9. In vivo priming of CD4 T cells that produce interleukin (IL)-2 but not IL-4 or interferon (IFN)-gamma, and can subsequently differentiate into IL-4- or IFN-gamma-secreting cells.
Wang X; Mosmann T
J Exp Med; 2001 Oct; 194(8):1069-80. PubMed ID: 11602637
[TBL] [Abstract][Full Text] [Related]
10. Enforced expression of GATA-3 in transgenic mice inhibits Th1 differentiation and induces the formation of a T1/ST2-expressing Th2-committed T cell compartment in vivo.
Nawijn MC; Dingjan GM; Ferreira R; Lambrecht BN; Karis A; Grosveld F; Savelkoul H; Hendriks RW
J Immunol; 2001 Jul; 167(2):724-32. PubMed ID: 11441076
[TBL] [Abstract][Full Text] [Related]
11. IL-12 augments CD8+ T cell development for contact hypersensitivity responses and circumvents anti-CD154 antibody-mediated inhibition.
Gorbachev AV; DiIulio NA; Fairchild RL
J Immunol; 2001 Jul; 167(1):156-62. PubMed ID: 11418644
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of T helper2 response in the absence of interleukin (IL-)6; an inhibition of IL-4-mediated T helper2 cell differentiation by IL-6.
Tanaka T; Katada Y; Higa S; Fujiwara H; Wang W; Saeki Y; Ohshima S; Okuda Y; Suemura M; Kishimoto T
Cytokine; 2001 Feb; 13(4):193-201. PubMed ID: 11237426
[TBL] [Abstract][Full Text] [Related]
13. Increased type 2 cytokine expression by both CD4+ CD45RO+ T cells and CD8+ CD45RO+ T cells in blood circulation is associated with high serum IgE but not with atopic dermatitis.
Sato A; Tsuji K; Yamamura M; Morita Y; Kanzaki H; Tada J; Makino H; Arata J
J Invest Dermatol; 1998 Dec; 111(6):1079-84. PubMed ID: 9856820
[TBL] [Abstract][Full Text] [Related]
14. CD8 T cells inhibit IgE via dendritic cell IL-12 induction that promotes Th1 T cell counter-regulation.
Thomas MJ; Noble A; Sawicka E; Askenase PW; Kemeny DM
J Immunol; 2002 Jan; 168(1):216-23. PubMed ID: 11751965
[TBL] [Abstract][Full Text] [Related]
15. IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response.
Hoshino T; Wiltrout RH; Young HA
J Immunol; 1999 May; 162(9):5070-7. PubMed ID: 10227975
[TBL] [Abstract][Full Text] [Related]
16. Constitutive expression of CIITA directs CD4 T cells to produce Th2 cytokines in the thymus.
Patel DR; Li W; Park JS; Sofi MH; Gourley TS; Hangoc G; Kaplan MH; Chang CH
Cell Immunol; 2005 Jan; 233(1):30-40. PubMed ID: 15876426
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells.
Batten M; Kljavin NM; Li J; Walter MJ; de Sauvage FJ; Ghilardi N
J Immunol; 2008 Mar; 180(5):2752-6. PubMed ID: 18292493
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroids enhance the capacity of macrophages to induce Th2 cytokine synthesis in CD4+ lymphocytes by inhibiting IL-12 production.
DeKruyff RH; Fang Y; Umetsu DT
J Immunol; 1998 Mar; 160(5):2231-7. PubMed ID: 9498762
[TBL] [Abstract][Full Text] [Related]
19. LPS-stimulated SJL macrophages produce IL-12 and IL-18 that inhibit IgE production in vitro by induction of IFN-gamma production from CD3intIL-2R beta+ T cells.
Yoshimoto T; Nagai N; Ohkusu K; Ueda H; Okamura H; Nakanishi K
J Immunol; 1998 Aug; 161(3):1483-92. PubMed ID: 9686615
[TBL] [Abstract][Full Text] [Related]
20. Microbial lipopeptides induce the production of IL-17 in Th cells.
Infante-Duarte C; Horton HF; Byrne MC; Kamradt T
J Immunol; 2000 Dec; 165(11):6107-15. PubMed ID: 11086043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
